• Aucun résultat trouvé

In 1991 the World Health Assembly endorsed Guiding Principles on Human Organ Transplantation

N/A
N/A
Protected

Academic year: 2022

Partager "In 1991 the World Health Assembly endorsed Guiding Principles on Human Organ Transplantation"

Copied!
3
0
0

Texte intégral

(1)

In the name of God, the Compassionate, the Merciful

Address by

DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR

WHO EASTERN MEDITERRANEAN REGION to the

CONSULTATION ON CELL TISSUE AND ORGAN TRANSPLANTATION Karachi, Pakistan, 26–28 November 2005

Your Excellencies, Ladies and Gentlemen, Dear Colleagues,

It gives us great pleasure to welcome you to perhaps the first scientific activity in Pakistan since the terrible earthquake, which horrified us all with its loss of life, level of injury and destruction of homes and lives, leaving so many without shelter, food or aid.

Truly, such catastrophes bring us all together. We were very proud to see Pakistan pulling together to face this natural disaster. Among those who set an example, and who is here with us today, is Dr Adib Rizvi and the Sindh Institute of Urology and Transplantation (SUIT), who put together three hospitals in the devastated areas for surgical care of the injured and for dialysis support.

I hope that WHO’s intervention continues to give support to the Ministry of Health in its endeavour to reestablish the health system in the affected areas.

(2)

2

Dear Colleagues,

Cell, tissue and organ transplantation raise many ethical, legal, cultural and clinical issues. In 1991 the World Health Assembly endorsed Guiding Principles on Human Organ Transplantation. These principles were developed following earlier World Health Assembly resolutions in 1987 and 1989, which primarily arose due to concerns about the commercial trafficking of human organs.

The field of transplantation has become increasingly complex and has continued to develop rapidly over the past few years. Issues related to transplantation were considered again in May 2004, when the World Health Assembly endorsed a resolution (WHA57.18) which, among other things, stressed the importance of effective oversight by national health authorities of allogeneic (human to human) and xenogeneic (animal to human) transplantation activities. This resolution also requested the Director-General of WHO to update the Guiding Principles on Human Organ Transplantation, in the light of data collected on the practices, safety, quality efficacy and epidemiology of transplantation, as well as on ethical issues. In addition, WHO was requested to promote international cooperation to facilitate the access of citizens to therapeutic allogeneic transplant procedures, and to facilitate international collaboration and communication on issues relating to xenogeneic transplantation.

Dear Colleagues,

In response, to this, WHO is, among other things, organizing a number of consultations globally. These consultations will enable discussion about transplantation issues from different cultural perspectives to ensure that the Guiding Principles on Human Organ Transplantation remain appropriate in a global context. This consultation is a key contribution to the global review from the Eastern Mediterranean and South-East Asia Regions and is graciously hosted by SUIT. In addition, the consultation will facilitate networking and collaboration between national health authorities which have responsibility for overseeing transplantation activities at country level.

(3)

3

Dear Colleagues,

I firmly believe that achieving these goals in within our reach provided that all of us ensure that the required ingredients are maintained. By this, I mean coordinating efforts, moving forward collectively and ensuring national commitment and the full support of partners.

Finally, I would like to assure you of WHO’s support and promotion of the concepts of safety, quality, efficacy, ethics and proper recording in transplantation, for both donor and recipient.

Once again, I would like to extend my appreciation to all of you for your efforts and for participating in this inter-regional consultation between the Eastern Mediterranean and South-East Asia Regions. I particularly would like to repeat my thanks to our host Professor Adib Rizvi and his colleagues from this centre of excellence, SUIT. Special thanks are due to Dr Luc Noel of WHO headquarters for supporting this consultation and to our facilitators who have come from different parts of the world to discuss with us this important issue.

I wish you fruitful discussions, a pleasant stay in Karachi, a city of art and heritage, and look forward to the recommendations and actions that your consultation will come out with, to further strengthen the important area of transplantation in our two collaborating regions.

Références

Documents relatifs

RECOMMENDS governments of Member States and Associate Members that they should endeavour to use the headings in Annex B of document A9/P&B/9 as the basis for their

Health Organization Regulations No, 1 the Regulations regarding Nomenclature (including the compilation and publication of statistics) with respect to diseases and causes of

In view of the increasing number of Member States which have indicated willingness to abolish the legal use of diacetylmorphine, it appears to the United States Delegation that

powered to re-allocate any substantial balances for which proposals from the countries concerned had not been received by 15 December 1948.52 The Board also authorized

NOTES the activities carried on in co-operation with the United Nations, specialized agencies and non-governmental organizations, and in particular the report 40 on the

In recognition of the need for a framework for action on diet and physical activity within the integrated approach to prevention and control of noncommunicable diseases, the WHA

(1) to draw attention to the public health impact of psoriasis, publishing a global report on psoriasis, including the global incidence and prevalence,

In view of the importance of the results and conclusions of recent conferences (Geneva, November 1995; Minsk, March 1996; Vienna, April 1996) summarizing the health effects 10